GEM-x Universal 5' Gene Expression v3, 16 Samples Tender, USA - 119306413

Procurement Summary

Country : USA

Summary : GEM-x Universal 5' Gene Expression v3, 16 Samples

Deadline : 20 May 2025

Other Information

Notice Type : Tender

TOT Ref.No.: 119306413

Document Ref. No. : RFQ-NIAID-25-2260513-REVISED

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items, ” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2260513 and the solicitation is issued as a Request for Quotes (RFQ).



This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-3 January 17, 2025.



The North American Industry Classification System (NAICS) code for this procurement is 325414, Biological Product (except Diagnostic) Manufacturing, with a size standard of 1, 250 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside.



Project Description:

The NIH, NIAID, BCIS has a current requirement for 10x Genomics reagents that are critical for experiments associated with the ongoing VRC328 clinical trial covered under Z#AI-005143-06. We are isolating PBMCs from whole blood samples and bulk sorting plasmablasts for single cell sequencing at specific study timepoints. Plasmablasts have limited recovery after freezing, so these cells must be processed immediately to remain viable for downstream sequencing analysis. The Chromium Single Cell 5- Reagent includes a gel bead emulsion (GEM) single cell 5- library and gel bead kit, accompanying library construction and barcoding kits, as well as B cell and T cell VDJ (BCR & TCR) enrichment kits and two different single index kits. The reagent described bu...
Active Contract Opportunity
Notice ID : RFQ-NIAID-25-2260513-REVISED
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
Updated Published Date: May 16, 2025 09:36 am EDT
Original Published Date: May 07, 2025 11:43 am EDT
Updated Date Offers Due: May 20, 2025 05:00 pm EDT
Original Date Offers Due: May 16, 2025 10:00 am EDT
Inactive Policy: 15 days after date offers due
Updated Inactive Date: Jun 04, 2025
Original Inactive Date: May 31, 2025
Initiative: None

Classification
Original Set Aside:

Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance: Bethesda, MD 20892 USA

Documents

 Tender Notice

RFQ-NIAID-25-2260513_Terms_and_Conditions_FAR_52.pdf